Biocartis

Biocartis

Foundation date

02/07/2010

Sector

#Medical Technology

Subsector

• #Therapeutics - Molecular diagnostics
• #Medtech - Diagnostic devices

Therapeutic areas

• #Infectious and parasitic diseases
• #Neoplasms / cancer / oncology

Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.

Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.